Designating April, in 2026 and in each succeeding year, as Myocarditis Awareness Month in Virginia.
House Joint Resolution 33 designates April 2026 and every April thereafter as Myocarditis Awareness Month in Virginia. The resolution states that myocarditis is an inflammatory heart disease that can cause serious symptoms, may be difficult to diagnose, and can lead to severe outcomes including heart failure or sudden death, particularly in young adults. It also notes the work of the Myocarditis Foundation in education, research, and patient support.
The measure is a ceremonial or commemorative resolution rather than a regulatory bill. It directs the Clerk of the House of Delegates to transmit a copy to the Myocarditis Foundation and to post the designation on the General Assembly’s website, but it does not create new enforcement mechanisms, funding, or substantive changes to health law. Its practical effect is to formally recognize the condition and encourage public awareness and support for affected individuals and families.
The overall sentiment reflected in the bill text is strongly supportive and sympathetic. The resolution emphasizes the seriousness of the disease, the need for awareness, and the value of research and compassionate support. Because there are no committee transcripts or recorded votes provided beyond passage by both chambers, there is no evidence of opposition in the available record.
No notable points of contention are apparent from the available materials. The resolution is noncontroversial in nature and appears aimed at public education and recognition rather than policy change. Any discussion would likely center on the appropriateness of using a joint resolution to highlight a health issue and the value of awareness campaigns for a relatively rare but potentially severe disease.
HJ33 does not amend the Code of Virginia or impose new duties on state agencies, local governments, health providers, or private parties. Its legal effect is limited to an official designation of April as Myocarditis Awareness Month in Virginia beginning in 2026 and continuing each year thereafter, along with administrative directives to the Clerk of the House of Delegates to notify the Myocarditis Foundation and post the designation online. The bill primarily affects public recognition and awareness efforts rather than substantive state law.
The sentiment surrounding HJ33 is positive and supportive. The resolution frames myocarditis as a serious and sometimes underdiagnosed disease and presents the awareness month as an opportunity to educate Virginians, encourage research, and support patients and families. With no recorded committee debate or votes showing dissent in the provided materials, the available record suggests broad, uncontroversial approval.
No specific contention is evident in the provided text or legislative history. The bill is a commemorative resolution, so any disagreement would likely be limited to general views about whether the General Assembly should issue awareness designations for health conditions. The available record does not show opposition from any particular chamber, committee, or stakeholder.